| Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms |
56 |
| Understanding the Physiopathology Behind Axial and Radial Diffusivity Changes - What Do we Know? |
52 |
| Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis |
50 |
| MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder |
46 |
| Parkinson's Disease and the Environment |
39 |
| A Multidimensional Approach to Post-concussion Symptoms in Mild Traumatic Brain Injury |
36 |
| EEG Source Imaging: A Practical Review of the Analysis Steps |
35 |
| On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease |
33 |
| Endocrine Crosstalk Between Skeletal Muscle and the Brain |
29 |
| Diagnostic Criteria for Parkinson's Disease: From James Parkinson to the Concept of Prodromal Disease |
29 |
| Potential of Stem Cell-Based Therapy for Ischemic Stroke |
28 |
| The Gut and Parkinson's Disease - A Bidirectional Pathway |
28 |
| Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage |
27 |
| The Multidisciplinary Approach to Alzheimer's Disease and Dementia. A Narrative Review of Non-Pharmacological Treatment |
27 |
| Basis of Shoulder Nerve Entrapment Syndrome: An Ultrasonographic Study Exploring Factors Influencing Cross-Sectional Area of the Suprascapular Nerve |
26 |
| Application of Metabolomics in Alzheimer's Disease |
26 |
| Cognitive Impairment in Multiple Sclerosis With Regards to Disease Duration and Clinical Phenotypes |
26 |
| Microglia and CNS Interleukin-1: Beyond Immunological Concepts |
25 |
| Novel TBC1D24 Mutations in a Case of Nonconvulsive Status Epilepticus |
25 |
| Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis |
24 |
| Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration |
24 |
| Inflammation, Infectious Triggers, and Parkinson's Disease |
24 |
| Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis |
24 |
| Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence |
24 |
| Perception of Verticality and Vestibular Disorders of Balance and Falls |
24 |
| Zebrafish as an Animal Model for Drug Discovery in Parkinson's Disease and Other Movement Disorders: A Systematic Review |
23 |
| Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease |
23 |
| Cognitive Involvement in Balance, Gait and Dual-Tasking in Aging: A Focused Review From a Neuroscience of Aging Perspective |
23 |
| The Role of BDNF in the Neuroimmune Axis Regulation of Mood Disorders |
22 |
| Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS |
22 |
| Impulse Control Disorders in Parkinson's Disease. A Brief and Comprehensive Review |
21 |
| Microglia in Alzheimer's Disease: Risk Factors and Inflammation |
21 |
| Mesenchymal Stem Cell-Derived Extracellular Vesicle Therapy for Stroke: Challenges and Progress |
21 |
| Inflammasome Proteins As Biomarkers of Multiple Sclerosis |
21 |
| Advances in the Potential Biomarkers of Epilepsy |
20 |
| Clinical Utilization of the FilmArray Meningitis/Encephalitis (ME) Multiplex Polymerase Chain Reaction (PCR) Assay |
20 |
| Spectral Analysis of Heart Rate Variability: Time Window Matters |
20 |
| Blood Biomarkers for Traumatic Brain Injury: A Quantitative Assessment of Diagnostic and Prognostic Accuracy |
19 |
| The Effect of Anxiety and Depression on Sleep Quality of Individuals With High Risk for Insomnia: A Population-Based Study |
19 |
| Diagnostic and Prognostic Performance of Neurofilaments in ALS |
19 |
| Olivocochlear Efferents in Animals and Humans: From Anatomy to Clinical Relevance |
19 |
| Otolithic Receptor Mechanisms for Vestibular-Evoked Myogenic Potentials: A Review |
19 |
| Transposable Elements, Inflammation, and Neurological Disease |
19 |
| Neuroplasticity of Language Networks in Aphasia: Advances, Updates, and Future Challenges |
19 |
| ISLES 2016 and 2017-Benchmarking Ischemic Stroke Lesion Outcome Prediction Based on Multispectral MRI |
19 |
| Tau Pathology in Parkinson's Disease |
19 |
| Ten Years of BrainAGE as a Neuroimaging Biomarker of Brain Aging: What Insights Have We Gained? |
18 |
| Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease |
18 |
| Full Spectrum of Reported Symptoms of Bilateral Vestibulopathy Needs Further Investigation-A Systematic Review |
18 |
| Motor Learning Deficits in Parkinson's Disease (PD) and Their Effect on Training Response in Gait and Balance: A Narrative Review |
18 |
